about
Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitolGlycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney diseaseGlycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort studyGlycemic control and survival in peritoneal dialysis patients with diabetes mellitus.Long-term effects of oral L-carnitine supplementation on anemia in chronic hemodialysis.Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease.V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients.Modeling red blood cell survival data.The Association between 25-Hydroxyvitamin D and Hemoglobin A1c Levels in Patients with Type 2 Diabetes and Stage 1-5 Chronic Kidney Disease.Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials.Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST)Clinical usefulness of the measurement of serum fructosamine in childhood diabetes mellitus.Predictors of anemia in a multi-ethnic chronic kidney disease population: a case-control study.Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D StudyAlterations of erythrocyte rheology and cellular susceptibility in end stage renal disease: Effects of peritoneal dialysisGlycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney DiseaseGlycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.Models for the red blood cell lifespan.Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c.Nocturnal hemodialysis improves erythropoietin responsiveness and growth of hematopoietic stem cells.An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease.Does the extracorporeal circulation worsen anemia in hemodialysis patients? Investigation with advanced microscopes of red blood cells drawn at the beginning and end of dialysisFactors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.Cytomegalovirus and anemia: not just for transplant anymore.A pharmacokinetic model for the glycation of albumin.Blood loss during vascular access cannulation: quantification using the weighed gauze and drape method.Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease.Altered Expression Pattern of CD55 and CD59 on Red Blood Cells in Anemia of Chronic Kidney Disease.Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.Hospitalization and mortality in hemodialysis patients: association with hemoglobin variability.Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease.
P2860
Q26801852-4167AB55-9326-411E-938B-586E7733AEB2Q26827458-9CC593F4-A222-4DDF-AB07-B80730B0FA1AQ30422123-B699979E-AB85-4A67-B9DD-860BA757B1E9Q30427058-D14C7F09-E983-4F0D-8220-3FF1CD95D235Q33625700-75A069E1-089C-4949-A1B5-547DEA0AD6BAQ33772931-3E3C1D84-1012-4223-980B-8BFC2807EFE3Q33892626-FDD1380A-2357-499B-8A7D-86CA1A4E22E9Q34047965-72120BD8-8A17-4095-A220-6230545A69C5Q34176759-C97492D4-E442-4D25-BFFC-EF3718BB7248Q34566117-FD075A04-649A-46BA-A2C6-37A08808CE73Q34613234-47E6478A-1380-4B0F-B395-7052C0005BDDQ35151878-7CCE8C51-46CD-436F-851C-2DD6F21545E9Q35419665-032BE4DA-DA4F-4372-A490-29DBAB671F4CQ35811858-EC094878-62B5-4100-90F0-FB37FF023D1BQ35886023-CFB63986-C3E0-4F48-A3C5-77C73F179905Q36169244-B7B6F496-F572-4628-9E86-2923801AFDA3Q36269951-A75347DD-CF09-463E-AABB-3D2647A6141FQ36512204-28777C0D-246D-47AA-A261-BEEFC5789914Q36939067-A555507C-0AB6-40F9-A859-CBD99B3A5202Q36952011-333BA8EE-02B8-4D21-AE1D-4A83FD8457F5Q36956072-6AB84F34-7602-4412-9EA3-B58D703E575AQ37123278-0EBA9308-13E1-4925-A439-156B66D457E1Q37141607-0DD4A38A-5AF9-49D5-B372-20D8D48B522AQ37233333-4BF2E0F3-3D1F-4BFE-898F-2C183ECEF7F2Q37257340-42803398-B1D1-4EA6-952F-B01D063495EAQ38182542-D83966D9-EC16-4447-AAF9-5CC8FEC6BFBFQ42096270-C39504B2-BB07-4849-9D70-CB2D1212DE3BQ42757541-4E658A98-A77B-4C36-A9DB-03200952FD9AQ45708671-A12A2106-AAE5-4B1A-A1B7-A3628EAF96B3Q46714166-202E00FE-8100-4D21-BB21-2BC0C92CCB9AQ48157066-7140923B-8556-4F26-83D4-D2E95DC85B9FQ49677687-5E54FF17-E431-40CC-9A3F-F57C26ED85A9Q50527011-4B0AFA86-78DD-49D4-9C6B-B7396FAB8A7DQ50978270-046EE2A2-5BF4-4A21-B33B-5E20429104C1Q54572186-C00A9A4A-138B-4B4E-A41A-BDBB7A47C762Q55431731-E02C6136-C9B1-422D-8C9C-FD784849D340
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Red blood cell survival in chronic renal failure.
@en
Red blood cell survival in chronic renal failure.
@nl
type
label
Red blood cell survival in chronic renal failure.
@en
Red blood cell survival in chronic renal failure.
@nl
prefLabel
Red blood cell survival in chronic renal failure.
@en
Red blood cell survival in chronic renal failure.
@nl
P2093
P1476
Red blood cell survival in chronic renal failure.
@en
P2093
Rosa Marticorena
Sandra Donnelly
P304
P356
10.1053/J.AJKD.2004.06.018
P577
2004-10-01T00:00:00Z